The Impact of RWE on U.S. Pharmaceutical Market Access Strategies
The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming the landscape of pharmaceutical development, pricing, and reimbursement strategies in the United States. To explore these advancements, the EVIDENCE 360: RWE, Pricing & Reimbursement Summit USA is scheduled for June 26-27, 2025, in Philadelphia.
Summit Overview
This two-day event aims to unite healthcare professionals, pharmaceutical leaders, policymakers, researchers, and data scientists to discuss the pivotal role of Real World Evidence in shaping healthcare poli
Like
Comment
Share
